Cora Gold CEO Bert Monro Talks Through Sanankoro’s Fast-Track to Production and Major Upside Potential
Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video)
Pharos Energy Positioned for Growth with Increased Drilling Momentum – Progressive Equity Research 18 December 2025
Elemental Royalty Poised for Growth in the Mid-Tier Precious Metals Sector, Says Cantor Fitzgerald 18 December 2025
RM Plc Strengthens Transformation Strategy with Equity Raise – Singer Capital Markets 17 December 2025
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025 22 January 2026
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
Cora Gold CEO Bert Monro Talks Through Sanankoro’s Fast-Track to Production and Major Upside Potential
Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video)
Pharos Energy Positioned for Growth with Increased Drilling Momentum – Progressive Equity Research 18 December 2025
Elemental Royalty Poised for Growth in the Mid-Tier Precious Metals Sector, Says Cantor Fitzgerald 18 December 2025
RM Plc Strengthens Transformation Strategy with Equity Raise – Singer Capital Markets 17 December 2025
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025 22 January 2026
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
Celcuity Inc. (CELC) Stock Report: A Biotechnology Pioneer with a 10.79% Potential Upside 2 January 2026
Standard BioTools Inc. (LAB) Stock Analysis: Exploring a Potential 21% Upside in the Medical Devices Sector 2 January 2026
Castle Biosciences, Inc. (CSTL) Stock Analysis: A Healthcare Innovator with Strong Buy Ratings and Promising Target Price 2 January 2026
Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring the 203% Upside Potential in Biotechnology 2 January 2026
Upstream Bio, Inc. (UPB) Stock Analysis: Biotech Innovator with a 75% Potential Upside 2 January 2026
Personalis, Inc. (PSNL) Stock Analysis: Exploring a 38% Upside Potential in the Healthcare Diagnostics Sector 2 January 2026
Surmodics, Inc. (SRDX) Stock Report: Navigating Challenges with Innovative Medical Solutions 2 January 2026
REGENXBIO Inc. (RGNX) Investor Outlook: Exploring a 110.86% Upside Potential in Gene Therapy Innovation 2 January 2026
Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a 115% Potential Upside Amidst Market Challenges 2 January 2026
CeriBell, Inc. (CBLL) Stock Analysis: Unpacking a 28.33% Potential Upside in the Medical Device Arena 2 January 2026
Oruka Therapeutics, Inc. (ORKA) Investor Outlook: 63% Upside Potential Sparks Interest in Biotech Innovator 2 January 2026
Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 42.78% Upside Potential in the Biotech Sector 2 January 2026
Iovance Biotherapeutics, Inc. (IOVA) Stock Report: Exploring a Potential 205% Upside Amidst Biotech Innovations 2 January 2026
Tectonic Therapeutic (TECX) Stock Analysis: Unveiling a 277% Upside Potential in Biotech Innovation 2 January 2026
Verastem, Inc. (VSTM) Investor Outlook: Exploring a Potential 107% Upside in the Biotech Sector 2 January 2026
Myriad Genetics, Inc. (MYGN): Investor Outlook Reveals 38% Upside Potential Amid Mixed Ratings 2 January 2026
Evolus, Inc. (EOLS) Stock Analysis: Exploring a Potential 178% Upside in the Aesthetic Market 2 January 2026
Bioventus Inc. (BVS) Stock Analysis: Exploring a 101.61% Upside Potential in the Healthcare Sector 2 January 2026
PureTech Health plc (PRTC) Stock Analysis: A Biotech Growth Story with 542.7% Revenue Surge 2 January 2026
Real Estate Credit Investments: Why 95% of Investors Voted to Stay In While Rivals Wind Down (Video) 5 January 2026
Real Estate Credit Investments Profiting From the Blind Spots in Property Lending (Video) 5 January 2026
NB Private Equity Returns Stay Strong as Exit Pipeline Builds and Buybacks Accelerate (Video) 19 December 2025
Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video) 17 December 2025
Harworth Group reports £110.2m FY2025 sales, driven by industrial & logistics disposals 19 January 2026
Cora Gold CEO Bert Monro Talks Through Sanankoro’s Fast-Track to Production and Major Upside Potential 2 June 2025
Pharos Energy Positioned for Growth with Increased Drilling Momentum – Progressive Equity Research 18 December 2025
Elemental Royalty Poised for Growth in the Mid-Tier Precious Metals Sector, Says Cantor Fitzgerald 18 December 2025
RM Plc Strengthens Transformation Strategy with Equity Raise – Singer Capital Markets 17 December 2025
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025 22 January 2026
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
